Clinical Trials in New York

Showing 18321-18340 of 22,668 trials

Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome

NCT02256475

This is a Phase 1b, open-label, multiple-dose study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of NBI-98854 in a total of 36 pediatric subjects with Tourette syndrome (TS). The study will be conducted in approximately 18 male and female children (6 to 11 years of age) and approximately 18 male and female adolescents (12 to 18 years of age). Both age groups will be divided equally into 3 dosing cohorts with 6 subjects each. Ascending doses will be evaluated as part of a staggered-cohort design. Study drug will be administered in each cohort for 14 consecutive days.

Tourette Syndrome

Neurocrine Biosciences36 participantsStarted Sep 2014

San Diego, California, United States • Kissimmee, Florida, United States • St. Petersburg, Florida, United States +7 more locations

TERMINATEDPhase 3< 1 mile

Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation

NCT00111488

The purpose of the Randomized Study of Surgical Ablation with Microwave Energy for the Treatment of Atrial Fibrillation (RESOLVE-AF) trial is to determine the safety and effectiveness of the Guidant FLEX® Microwave Surgical Ablation System in the treatment of permanent atrial fibrillation (AF).

Atrial Fibrillation

Boston Scientific Corporation200 participantsStarted Jun 2005

La Jolla, California, United States • Long Beach, California, United States • Los Angeles, California, United States +18 more locations

Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome

Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation

Find Trials by Condition in New York

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Percutaneous Renal Tumor Cryoablation Followed by Biopsy

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Racial and Ethnic Disparities in Acute Pain Control

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)